{"schema_version":"secwatch.filing_event.v1","accession":"0000885725-23-000038","form_type":"8-K","ticker":"BSX","cik":"0000885725","company_name":"BOSTON SCIENTIFIC CORP","filed_at":"2023-06-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.615764+00:00","generated_at":"2026-06-13T16:43:12.978951+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Boston Scientific elects Jessica L. Mega and Susan E. Morano to board of directors","bullets":["Dr. Mega is co-founder of Verily Life Sciences (Alphabet) and former chief medical officer; cardiologist at Brigham & Women's.","Ms. Morano was VP of Business Development and Strategic Operations at Johnson & Johnson MedTech until Feb 2023.","Board expanded from 10 to 11; appointments effective June 27, 2023, with prorated cash retainer ~$97,715 and equity award ~$174,188.","Dr. Mega joins Compensation and Risk Committees; Ms. Morano joins Audit and Nominating & Governance Committees."],"urls":{"canonical":"https://secwatch.observer/filing/0000885725-23-000038","json":"https://secwatch.observer/filing/0000885725-23-000038.json","markdown":"https://secwatch.observer/filing/0000885725-23-000038.md","text":"https://secwatch.observer/filing/0000885725-23-000038.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/885725/000088572523000038/0000885725-23-000038-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/885725/000088572523000038/bsx-20230627.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T16:43:12.978951+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"238f355990","claim":"Jessica L. Mega was appointed as director at BOSTON SCIENTIFIC CORP.","evidence_excerpt":"appointed each of Jessica L. Mega, MD, MPH and Susan E. Morano to be a director of the Company, to hold office until the next annual meeting of stockholders, in each case, effective June 27, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/885725/000088572523000038/0000885725-23-000038-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"director"}],"fact_type":"executive_change"},{"claim_id":"7e84175257","claim":"Susan E. Morano was appointed as director at BOSTON SCIENTIFIC CORP.","evidence_excerpt":"appointed each of Jessica L. Mega, MD, MPH and Susan E. Morano to be a director of the Company, to hold office until the next annual meeting of stockholders, in each case, effective June 27, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/885725/000088572523000038/0000885725-23-000038-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}